Table 2.

Main outcome measures, IOP, BCVA, number of ocular hypotensive medications, and mean deviation on visual field at preoperative and follow-up visits for all patients.

Timepoint	IOP (mmHg)			Ocular hypotensive medications			BCVA		Visual field test
	N	Mean ± SD	p value	N	Mean ± SD	p value	LogMAR (mean ± SD)	p value	Mean deviation ± SD (dB)
Preoperative	76	14.7 ± 3.7	–	76	2.6 ± 1.5	–	0.36 ± 0.12	–	−9.21 ± 7.71
Postoperative day 1	76	11.2 ± 4.1	<0.00010	76	0	–	–	–	–
1 month	74	14.9 ± 5.0 (range:6–36)	0.83	74	0.17 ± 0.74	<0.00010	0.21 ± 0.33	<0.00010	–
3 months	71	13.3 ± 3.2	0.0022	71	0.63 ± 1.2	<0.00010	0.18 ± 0.39	<0.00010	–
6 months	76	13.9 ± 4.3	0.25	76	0.72 ± 1.4	<0.00010	0.17 ± 0.38	<0.00010	−9.11 ± 8.16 (p = 0.22)

BCVA, best-corrected visual acuity; IOP, intraocular pressure; n, number of patients; SD, standard deviation.